GLOBAL MORQUIO SYNDROME (MPS-IV) DRUG MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2023 - 2030)

Global Morquio Syndrome (MPS-IV) Drug Market, By Product Type (Solid Dosage Form, Liquid Dosage Form), By Treatment (Enzyme Replacement Therapy, Hematopoietic Stem Cell Therapy, Gene Therapy, Others), By Disease Type (Morquio A, Morquio B), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : Jan 2024
Code : CMI6563
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Global Morquio Syndrome (MPS-IV) Drug Market Size and Trends

Global morquio syndrome (MPS-IV) drug market size is expected to reach US$ 4.3 Mn by 2031 from US$ 1.9 Mn in 2024, exhibiting a compound annual growth rate (CAGR) of 12.4% during the forecast period.

Global Morquio Syndrome (MPS-IV) Drug Market - Trends

Focus on gene therapy and enzyme replacement therapy: The trend of gene therapy and enzyme replacement therapy is having a significant influence on the global morquio syndrome (MPS-IV) drug market. As these innovative therapies provide hope for more effective treatment options, there is growing interest and investment in the development of gene and enzyme therapies for MPS-IV. The promise of more effective therapies than current treatments is reshaping competitive dynamics in the MPS-IV drug market. Traditional enzyme replacement therapies, while helping manage symptoms, cannot cure MPS-IV or stop its progression. Gene therapies and novel enzyme therapies aim to address the underlying genetic defects and could potentially be curative if clinical trials prove successful.